Vol 74, No 5 (2016)
Letters to the Editor
Published online: 2016-05-17
Response to the letter concerning the article “Rivaroxaban in secondary cardiogenic stroke prevention: two-year single-centre experience based on follow-up of 209 patients”
DOI: 10.5603/KP.2016.0073
Kardiol Pol 2016;74(5):506.
Abstract
Not available
